$20.18 Million in Sales Expected for IntriCon Co. (NASDAQ:IIN) This Quarter
Equities analysts predict that IntriCon Co. (NASDAQ:IIN) will report $20.18 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for IntriCon’s earnings, with the highest sales estimate coming in at $20.80 million and the lowest estimate coming in at $19.55 million. IntriCon posted sales of $29.34 million during the same quarter last year, which suggests a negative year over year growth rate of 31.2%. The business is expected to report its next quarterly earnings results on Tuesday, August 4th.
According to Zacks, analysts expect that IntriCon will report full-year sales of $93.89 million for the current fiscal year, with estimates ranging from $93.87 million to $93.90 million. For the next year, analysts expect that the firm will post sales of $114.36 million, with estimates ranging from $108.60 million to $120.12 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover IntriCon.
IntriCon (NASDAQ:IIN) last issued its quarterly earnings results on Tuesday, May 19th. The technology company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.13). IntriCon had a negative return on equity of 1.35% and a negative net margin of 6.19%. The firm had revenue of $21.50 million during the quarter, compared to analysts’ expectations of $21.54 million.
IntriCon stock traded down $0.49 during trading on Wednesday, reaching $13.11. The stock had a trading volume of 39,500 shares, compared to its average volume of 66,294. IntriCon has a 52-week low of $9.84 and a 52-week high of $23.57. The business has a 50 day moving average price of $13.47 and a 200 day moving average price of $14.64. The company has a quick ratio of 3.03, a current ratio of 4.14 and a debt-to-equity ratio of 0.03. The stock has a market cap of $119.82 million, a PE ratio of -17.72 and a beta of 1.00.
Several institutional investors have recently made changes to their positions in IIN. Russell Investments Group Ltd. boosted its position in shares of IntriCon by 30.1% in the 1st quarter. Russell Investments Group Ltd. now owns 577,597 shares of the technology company’s stock worth $6,797,000 after buying an additional 133,661 shares in the last quarter. Gamco Investors INC. ET AL boosted its position in shares of IntriCon by 16.4% in the 1st quarter. Gamco Investors INC. ET AL now owns 515,450 shares of the technology company’s stock worth $6,067,000 after buying an additional 72,800 shares in the last quarter. Mairs & Power INC boosted its position in shares of IntriCon by 5.3% in the 4th quarter. Mairs & Power INC now owns 307,166 shares of the technology company’s stock worth $5,529,000 after buying an additional 15,350 shares in the last quarter. Teton Advisors Inc. boosted its position in shares of IntriCon by 11.5% in the 1st quarter. Teton Advisors Inc. now owns 193,724 shares of the technology company’s stock worth $2,280,000 after buying an additional 20,000 shares in the last quarter. Finally, State Street Corp lifted its holdings in IntriCon by 7.3% in the 4th quarter. State Street Corp now owns 148,609 shares of the technology company’s stock valued at $2,675,000 after purchasing an additional 10,134 shares in the last quarter. 72.29% of the stock is currently owned by institutional investors and hedge funds.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.